Two Major New Ovarian Cancer Approvals — Expanding Access To PARP Inhibitors

Updated September 7th, 2022

Two Major New Ovarian Cancer Approvals — Expanding Access To PARP Inhibitors

NOW
PLAYING
Radiation Boom--The Increasingly Popular Choice For Later Stage Cancer
NOW
PLAYING
Mom Discovers Inoperable Cancer Six Months After Beating Disease
NOW
PLAYING
Pelé Hospitalized For Chemo Treatment In Colon Cancer Battle
NOW
PLAYING
Cancer Patient's Chemo Surgery Cancelled Three Times Due To COVID
NOW
PLAYING
Teacher Battling Stage IV Ovarian Cancer After Only Weeks of Symptoms
NOW
PLAYING
Rex Tillerson Thought Kidney Cancer Symptoms Were White House Stress

Patient Pathfinder:

Clinical Trial Finder

Are you looking for other treatment options?
Right now there are ... ovarian cancer trials in the U.S. within 100 miles of

Enter your zip code and travel distance to explore trials in your area...

Maintenance: PARP Inhibitors as a Maintenance Tool

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.